Intravenous (IV) Bortezomib Infusion After Non-Response to Subcutaneous Bortezomib Administration Can Induce Transitory Responses in Multiple Myeloma Patients: Are Some Patients More Sensitive to IV Bortezomib?
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14032
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 11, 2016
Authors
Publisher
Wiley